Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma

被引:14
|
作者
Furtado, Michelle [1 ,2 ]
Wang, Michael L. [3 ]
Munneke, Brian [4 ]
McGreivy, Jesse [4 ]
Beaupre, Darrin M. [4 ]
Rule, Simon [1 ,2 ]
机构
[1] Univ Plymouth, Sch Med, Plymouth PL4 8AA, Devon, England
[2] Univ Plymouth, Sch Dent, Plymouth PL4 8AA, Devon, England
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Pharmacyclics Inc, Sunnyvale, CA USA
关键词
bone marrow; bruton tyrosine kinase inhibitor; ibrutinib; lymphocytosis; mantle cell lymphoma; BRUTON TYROSINE KINASE; INHIBITOR IBRUTINIB; TARGETING BTK; PCI-32765; LEUKEMIA; DISEASE;
D O I
10.1111/bjh.13275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:131 / 134
页数:4
相关论文
共 50 条
  • [1] Ibrutinib associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma
    Furtado, M. V.
    Munneke, B.
    Wang, M.
    Beaupre, D.
    McGreivy, J.
    Rule, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 64 - 64
  • [2] Ibrutinib-associated Serositis in Mantle Cell Lymphoma
    Styskel, Brett A.
    Lopez-Mattei, Juan
    Jimenez, Carlos A.
    Stewart, John
    Hagemeister, Fredrick B.
    Faiz, Saadia A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : E43 - E44
  • [3] Bone marrow involvement in mantle cell lymphoma
    Naresh, Kikkeri
    Hartley, Sarah
    Macdonald, Donald
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (06) : 446 - 446
  • [4] Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report
    Kaur, Varinder
    Swami, Arjun
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (03) : 235 - 239
  • [5] Early bone marrow involvement by mantle cell lymphoma
    Clement, Parker W.
    Salama, Mohamed E.
    BLOOD, 2015, 126 (06) : 825 - 825
  • [6] Mantle cell lymphoma - Morphologic findings in bone marrow involvement
    Wasman, J
    Rosenthal, NS
    Farhi, DC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (02) : 196 - 200
  • [7] Bone marrow and peripheral blood involvement in mantle cell lymphoma
    Cohen, PL
    Kurtin, PJ
    Donovan, KA
    Hanson, CA
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (02) : 302 - 310
  • [8] Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature
    Titus-Rains, Krystal S.
    Brown, Jamie N.
    Hammond, Julia M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 544 - 549
  • [9] Ibrutinib for mantle cell lymphoma
    Tucker, David L.
    Rule, Simon A.
    FUTURE ONCOLOGY, 2016, 12 (04) : 477 - 491
  • [10] Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
    Rudelius, Martina
    Rosenfeldt, Mathias Tillmann
    Leich, Ellen
    Rauert-Wunderlich, Hilka
    Solimando, Antonio Giovanni
    Beilhack, Andreas
    Ott, German
    Rosenwald, Andreas
    HAEMATOLOGICA, 2018, 103 (01) : 116 - 125